Permanent Hair Loss More Likely in New Cancer Drug -Taxotere

Share This Article

Taxotere is the most-widely prescribed chemotherapy drug used to treat breast cancer. Up to 75 percent of breast cancer patients in the United States use Taxotere during their treatment. It is also used to treat certain lung, stomach, prostate and head and neck cancers.

Breast cancer is the most common cancer in women in the United States, not counting some kinds of skin cancer. In 2012, more than 220,000 women and 2,000 men were diagnosed with some form of breast cancer, and the American Cancer Society estimates over 300,000 new cases of breast cancer will be diagnosed in 2016.

Taxotere is an effective form of breast cancer treatment. The drug’s main ingredient, docetaxel, works by stopping cancer cells from dividing, or duplicating themselves, eventually leading to the cancer cells’ deaths. It is given intravenously in doses based on a patient’s weight and height. One can  also hire Taxotere Lawyers If you or a loved suffer from permanent hair loss and you really want to take any legal action against Sanofi.

Despite its effectiveness, Taxotere may cause a significant side effect that many cancer survivors never expect to suffer from: permanent alopecia, or permanent hair loss. Though many patients accept temporary hair loss as a side effect of chemotherapy treatment, they expect the hair they lost to grow back after treatment has ended. For many patients taking Taxotere, that is not the case.

A Taxotere hair loss lawsuit may be an option for patients who suffered from permanent hair loss after taking the drug as a part of their chemotherapy treatment for certain forms of cancer. Specifically, lawsuits allege that women who were treated with the drug for breast cancer experienced disfiguring permanent hair loss.